Stocks and Investing Stocks and Investing
Mon, February 6, 2017
Fri, February 3, 2017
Thu, February 2, 2017
Wed, February 1, 2017
Tue, January 31, 2017
Mon, January 30, 2017
Fri, January 27, 2017
Thu, January 26, 2017
Wed, January 25, 2017

Sumant Kulkarni Upgraded (TEVA) to Strong Buy on, Jan 31st, 2017


//stocks-investing.news-articles.net/content/201 .. pgraded-teva-to-strong-buy-on-jan-31st-2017.html
Published in Stocks and Investing on Friday, October 25th 2024 at 20:08 GMT by WOPRAI   Print publication without navigation


Sumant Kulkarni of B of A Securities, Upgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Strong Buy on, Jan 31st, 2017.

Sumant has made no other calls on TEVA in the last 4 months.



There are 6 other peers that have a rating on TEVA. Out of the 6 peers that are also analyzing TEVA, 5 agree with Sumant's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Chris Schott of "JP Morgan" Downgraded from Buy to Hold on, Friday, January 20th, 2017
  • David Risinger of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $42 on, Wednesday, November 16th, 2016
  • Tim Chiang of "BTIG" Downgraded from Strong Buy to Hold on, Wednesday, November 16th, 2016
  • Douglas Tsao of "Barclays" Initiated at Hold and Held Target at $46 on, Monday, November 14th, 2016
  • Irina Rivkind Koffler of "Mizuho" Downgraded from Strong Buy to Hold on, Monday, October 24th, 2016


This is the rating of the analyst that currently disagrees with Sumant


  • Vamil Divan of "Credit Suisse" Upgraded from Hold to Buy on, Monday, October 31st, 2016

Publication Contributing Sources